Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 80

1.

[A rare tympanic lesion - paracentesis led to an interesting diagnosis].

Stapper MC, Kirchesch D, Krömeke O, Glaas MF, Zollner B, Albert NL, Kunz M.

Laryngorhinootologie. 2018 Sep;97(9):636-638. doi: 10.1055/a-0648-4710. Epub 2018 Jul 12. German. No abstract available.

PMID:
30001563
2.

Recurrence pattern analysis after [68Ga]-DOTATATE-PET/CT -planned radiotherapy of high-grade meningiomas.

Zollner B, Ganswindt U, Maihöfer C, Corradini S, Albert NL, Schichor C, Belka C, Niyazi M.

Radiat Oncol. 2018 Jun 14;13(1):110. doi: 10.1186/s13014-018-1056-4.

3.

Stereoscopic X-ray imaging, cone beam CT, and couch positioning in stereotactic radiotherapy of intracranial tumors: preliminary results from a cross-modality pilot installation.

Zollner B, Heinz C, Pitzler S, Manapov F, Kantz S, Rottler MC, Niyazi M, Ganswindt U, Belka C, Ballhausen H.

Radiat Oncol. 2016 Dec 7;11(1):158.

4.

Pharmacases.de - a student-centered e-learning project of clinical pharmacology.

Zollner B, Sucha M, Berg C, Muß N, Amann P, Amann-Neher B, Oestreicher D, Engelhardt S, Sarikas A.

Med Teach. 2013;35(3):251-3. doi: 10.3109/0142159X.2013.759642. Epub 2013 Jan 22.

PMID:
23339530
5.

Selection and counterselection of the rtI233V adefovir resistance mutation during antiviral therapy.

Schildgen O, Olotu C, Funk A, Zöllner B, Helm M, Rockstroh JK, Sirma H.

J Clin Microbiol. 2010 Feb;48(2):631-4. doi: 10.1128/JCM.01073-09. Epub 2009 Dec 9.

6.

Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

Steininger C, Graninger W, Zoufaly A, Zöllner B, Feucht HH, Kundi M, Stahmer I, Stellbrink HJ, van Lunzen J.

Eur J Med Res. 2008 Jun 24;13(6):304-8.

PMID:
18558558
7.

Temporary HBV resolution in an HIV-coinfected patient during HBV-directed combination therapy followed by relapse of HBV.

Wursthorn K, Buggisch P, Lutgehetmann M, Zollner B, Petersen J.

Antivir Ther. 2006;11(5):647-52.

PMID:
16964835
8.

Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B.

Wursthorn K, Lutgehetmann M, Dandri M, Volz T, Buggisch P, Zollner B, Longerich T, Schirmacher P, Metzler F, Zankel M, Fischer C, Currie G, Brosgart C, Petersen J.

Hepatology. 2006 Sep;44(3):675-84.

PMID:
16941693
9.

Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

van Bömmel F, Zöllner B, Sarrazin C, Spengler U, Hüppe D, Möller B, Feucht HH, Wiedenmann B, Berg T.

Hepatology. 2006 Aug;44(2):318-25.

PMID:
16871563
10.

Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier.

Zöllner B, Feucht HH, Sterneck M, Schäfer H, Rogiers X, Fischer L.

Liver Transpl. 2006 Aug;12(8):1283-9.

11.

Detection of minor populations of drug-resistant HIV-1 in acute seroconverters.

Metzner KJ, Rauch P, Walter H, Boesecke C, Zöllner B, Jessen H, Schewe K, Fenske S, Gellermann H, Stellbrink HJ.

AIDS. 2005 Nov 4;19(16):1819-25.

PMID:
16227789
12.
13.
14.

Fatal influenza A infection with Staphylococcus aureus superinfection in a 49-year-old woman presenting as sudden death.

Tsokos M, Zöllner B, Feucht HH.

Int J Legal Med. 2005 Jan;119(1):40-3. Epub 2004 Aug 19.

PMID:
15322829
15.

Changes in the prevalence of hepatitis C virus genotype among injection drug users: a highly dynamic process.

Schroter M, Zollner B, Laufs R, Feucht HH.

J Infect Dis. 2004 Sep 15;190(6):1199-200; author reply 1200-1. No abstract available.

PMID:
15319872
16.

Viral features of lamivudine resistant hepatitis B genotypes A and D.

Zöllner B, Petersen J, Puchhammer-Stöckl E, Kletzmayr J, Sterneck M, Fischer L, Schröter M, Laufs R, Feucht HH.

Hepatology. 2004 Jan;39(1):42-50.

PMID:
14752821
17.
18.

Multiple infections with different HCV genotypes: prevalence and clinical impact.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

J Clin Virol. 2003 Jul;27(2):200-4.

PMID:
12829042
19.

A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Feucht HH.

J Clin Virol. 2003 May;27(1):69-73.

PMID:
12727531
20.

[Hepatitis C. Virology, transmission modes, clinical aspects, prevention and therapy].

Laufs R, Polywka S, Feucht HH, Schröter M, Zöllner B, Oehler G.

Anaesthesist. 2002 Nov;51(11):884-9. Review. German.

PMID:
12434261
21.

Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany.

Schröter M, Laufs R, Zöllner B, Knödler B, Schäfer P, Sterneck M, Fischer L, Feucht HH.

J Viral Hepat. 2002 Nov;9(6):455-9.

PMID:
12431209
22.

The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.

Fischer L, Sterneck M, Meier D, Zöllner B, Rogiers X.

Transplant Proc. 2002 Sep;34(6):2283-4. No abstract available.

PMID:
12270400
23.

Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes.

Schröter M, Zöllner B, Schäfer P, Landt O, Lass U, Laufs R, Feucht HH.

J Clin Microbiol. 2002 Jun;40(6):2046-50.

24.

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Schröter M, Zöllner B, Schäfer P, Reimer A, Müller M, Laufs R, Feucht HH.

J Clin Microbiol. 2002 May;40(5):1866-8.

25.

Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment.

Zöllner B, Petersen J, Schäfer P, Schröter M, Laufs R, Sterneck M, Feucht HH.

Clin Infect Dis. 2002 May 1;34(9):1273-7. Epub 2002 Apr 2.

PMID:
11941556
26.

Correlation of hepatitis B virus load with loss of e antigen and emerging drug-resistant variants during lamivudine therapy.

Zöllner B, Schäfer P, Feucht HH, Schröter M, Petersen J, Laufs R.

J Med Virol. 2001 Dec;65(4):659-63.

PMID:
11745928
27.

Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy.

Albrecht D, Zöllner B, Feucht HH, Lorenzen T, Laufs R, Stoehr A, Plettenberg A.

J Clin Virol. 2002 Feb;24(1-2):93-8.

PMID:
11744433
28.

Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Virol. 2001 Dec;23(1-2):57-63.

PMID:
11595584
29.

Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients.

Schäfer P, Tenschert W, Cremaschi L, Schröter M, Zöllner B, Laufs R.

J Med Virol. 2001 Sep;65(1):85-9.

PMID:
11505448
30.

Strategies for reliable diagnosis of hepatitis C infection: the need for a serological confirmatory assay.

Schröter M, Schäfer P, Zöllner B, Polywka S, Laufs R, Feucht HH.

J Med Virol. 2001 Jul;64(3):320-4.

PMID:
11424121
31.

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.

Zöllner B, Feucht HH, Schröter M, Schäfer P, Plettenberg A, Stoehr A, Laufs R.

AIDS. 2001 May 4;15(7):935-6. No abstract available.

PMID:
11399967
32.

20-fold increase in risk of lamivudine resistance in hepatitis B virus subtype adw.

Zöllner B, Petersen J, Schröter M, Laufs R, Schoder V, Feucht HH.

Lancet. 2001 Mar 24;357(9260):934-5.

PMID:
11289355
33.

Relevance of reactivity in commercially available hepatitis C virus antibody assays.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

J Clin Microbiol. 2001 Apr;39(4):1665-8.

34.

Application of HIV-1 genotypic-resistance testing prevents the evolution of further resistance mutations in heavily pretreated patients.

Zöllner B, Feucht HH, Weitner L, Adam A, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2001 Apr;21(1):37-45.

PMID:
11255096
35.

Prevalence of a novel DNA virus (TTV) among patients on maintenance hemodialysis.

Schröter M, Feucht HH, Zöllner B, Schäfer P, Laufs R.

Nephron. 2001 Feb;87(2):139-42.

PMID:
11244308
36.

Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays.

Schröter M, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2001 Feb;39(2):765-8.

37.

Lamivudine improves the prognosis of patients with hepatitis B after liver transplantation.

Fischer L, Sterneck M, Zöllner B, Rogiers X.

Transplant Proc. 2000 Nov;32(7):2128-30. No abstract available.

PMID:
11120099
38.

[Evaluating form and function of the nose after open rhinoplasty in unilateral lip-maxillopalatal clefts].

Werkmeister R, Zöllner B, Kiattavorncharoen S, Joos U.

Mund Kiefer Gesichtschir. 2000 Sep;4(5):270-3. German.

PMID:
11092177
39.

In vivo dynamics and pathogenicity of wild-type and resistant Hepatitis B virus during long-term lamivudine monotherapy - a clinical note.

Zöllner B, Stoehr A, Plettenberg A, Feucht H, Schröter M, Schäfer P, Laufs R.

J Clin Virol. 2000 Sep 1;17(3):183-8.

PMID:
10996115
40.

Rapid clearance of human immunodeficiency virus type 1 from ventricular cerebrospinal fluid during antiretroviral treatment.

Eggers C, Stuerenburg HJ, Schafft T, Zöllner B, Feucht HH, Stellbrink HJ, van Lunzen J.

Ann Neurol. 2000 Jun;47(6):816-9.

PMID:
10852550
41.

Detection of TT virus DNA and GB virus type C/Hepatitis G virus RNA in serum and breast milk: determination of mother-to-child transmission.

Schröter M, Polywka S, Zöllner B, Schäfer P, Laufs R, Feucht HH.

J Clin Microbiol. 2000 Feb;38(2):745-7.

42.

Low risk of vertical transmission of hepatitis C virus by breast milk.

Polywka S, Schröter M, Feucht HH, Zöllner B, Laufs R.

Clin Infect Dis. 1999 Nov;29(5):1327-9.

PMID:
10524987
43.

Drug-resistant genotyping in HIV-1 therapy.

Zöllner B, Feucht HH, Weitner L, Adam A, Laufs R.

Lancet. 1999 Sep 25;354(9184):1120-1. No abstract available.

PMID:
10509522
44.

[Examining patients with facial skull fractures from an etiological and legal perspective].

Meyer U, Benthaus S, Du Chesne A, Wannhof H, Zöllner B, Joos U.

Mund Kiefer Gesichtschir. 1999 May;3(3):152-7. German.

PMID:
10414114
45.

High rate of chronicity in HCV infection determined by antibody confirmatory assay and PCR in 4110 patients during long-term follow-up.

Feucht HH, Zöllner B, Schröter M, Polywka S, Buggisch P, Nolte H, Laufs R.

J Clin Virol. 1999 Jun;13(1-2):43-51.

PMID:
10405891
46.

Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.

Schröter M, Feucht HH, Schäfer P, Zöllner B, Laufs R.

J Clin Microbiol. 1999 Aug;37(8):2576-80.

47.

Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Feucht HH, Schröter M, Zöllner B, Polywka S, Laufs R.

J Clin Microbiol. 1999 May;37(5):1294-7.

48.
49.

TT virus viremia and liver transplantation: no significant increase of the prevalence.

Schröter M, Feucht HH, Schäfer P, Zöllner B, Laufs R, Knödler B.

Blood. 1998 Dec 15;92(12):4877-8. No abstract available.

Supplemental Content

Loading ...
Support Center